Yan C - Search Results

1

Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC).

Hui Z, Zhang J, Ren Y, Li X, Yan C, Yu W, Wang T, Xiao S, Chen Y, Zhang R, Wei F, You J, Ren X. Hui Z, et al. Among authors: yan c. Cell Death Dis. 2022 Jul 13;13(7):607. doi: 10.1038/s41419-022-05057-4. Cell Death Dis. 2022. PMID: 35831283 Free PMC article.

2

Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.

Wang Y, Gao X, Wei F, Zhang X, Yu J, Zhao H, Sun Q, Yan F, Yan C, Li H, Ren X. Wang Y, et al. Among authors: yan f, yan c. Gene. 2014 Jan 1;533(1):389-97. doi: 10.1016/j.gene.2013.09.038. Epub 2013 Sep 26. Gene. 2014. PMID: 24076132 Review.

3

Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer.

Yu J, Wang Y, Yan F, Zhang P, Li H, Zhao H, Yan C, Yan F, Ren X. Yu J, et al. Among authors: yan f, yan c. J Immunol. 2014 Sep 1;193(5):2574-86. doi: 10.4049/jimmunol.1400833. Epub 2014 Jul 25. J Immunol. 2014. PMID: 25063873 Free PMC article. Clinical Trial.

4

The hOGG1 Ser326Cys polymorphism contributes to digestive system cancer susceptibility: evidence from 48 case-control studies.

Wang Y, Gao X, Wei F, Zhang X, Yu J, Zhao H, Sun Q, Yan F, Yan C, Li H, Ren X. Wang Y, et al. Among authors: yan f, yan c. Tumour Biol. 2015 Feb;36(2):1029-38. doi: 10.1007/s13277-014-2710-6. Epub 2014 Oct 17. Tumour Biol. 2015. PMID: 25323581

5

Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection.

Yan CH, Lv M, Li H, Song X, Yan F, Cao S, Ren X. Yan CH, et al. J Cancer Res Clin Oncol. 2015 Aug;141(8):1371-8. doi: 10.1007/s00432-014-1902-1. Epub 2015 Jan 3. J Cancer Res Clin Oncol. 2015. PMID: 25555465

6

Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects.

Yan C, Song X, Yu W, Wei F, Li H, Lv M, Zhang X, Ren X. Yan C, et al. Tumour Biol. 2016 Jun;37(6):8425-35. doi: 10.1007/s13277-015-4746-7. Epub 2016 Jan 5. Tumour Biol. 2016. PMID: 26733169

7

HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma.

Zheng H, Zhao W, Yan C, Watson CC, Massengill M, Xie M, Massengill C, Noyes DR, Martinez GV, Afzal R, Chen Z, Ren X, Antonia SJ, Haura EB, Ruffell B, Beg AA. Zheng H, et al. Among authors: yan c. Clin Cancer Res. 2016 Aug 15;22(16):4119-32. doi: 10.1158/1078-0432.CCR-15-2584. Epub 2016 Mar 10. Clin Cancer Res. 2016. PMID: 26964571 Free PMC article.

8

Adoptive Cellular Therapy (ACT) for Cancer Treatment.

Yang F, Jin H, Wang J, Sun Q, Yan C, Wei F, Ren X. Yang F, et al. Among authors: yan c. Adv Exp Med Biol. 2016;909:169-239. doi: 10.1007/978-94-017-7555-7_4. Adv Exp Med Biol. 2016. PMID: 27240459 Review.

9

Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells.

Liu L, Zhang L, Yang L, Li H, Li R, Yu J, Yang L, Wei F, Yan C, Sun Q, Zhao H, Yang F, Jin H, Wang J, Wang SE, Ren X. Liu L, et al. Among authors: yan c. Front Immunol. 2017 Apr 21;8:404. doi: 10.3389/fimmu.2017.00404. eCollection 2017. Front Immunol. 2017. PMID: 28484448 Free PMC article.

10

Chemoradiotherapy-Induced CD4⁺ and CD8⁺ T-Cell Alterations to Predict Patient Outcomes in Esophageal Squamous Cell Carcinoma.

Chen X, Zhang W, Qian D, Guan Y, Wang Y, Zhang H, Er P, Yan C, Li Y, Ren X, Pang Q, Wang P. Chen X, et al. Among authors: yan c. Front Oncol. 2019 Feb 15;9:73. doi: 10.3389/fonc.2019.00073. eCollection 2019. Front Oncol. 2019. PMID: 30828566 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,893 results

Search Page